Idiaqua Injection contains Diclofenac 75mg, a nonsteroidal anti-inflammatory drug (NSAID) used for the management of pain and inflammation associated with various musculoskeletal disorders, postoperative pain, and acute injury-related conditions. Diclofenac exerts its therapeutic effects by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, leading to a decreased synthesis of prostaglandins, which are mediators of inflammation and pain. This injectable formulation allows for rapid onset of action, making it suitable for patients requiring prompt relief from moderate to severe pain. Idiaqua Injection is indicated for conditions such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and soft tissue injuries. It should be administered intramuscularly or intravenously as per the prescribing physician’s instructions. Caution is advised in patients with a history of gastrointestinal ulcers, bleeding disorders, cardiovascular diseases, or renal impairment, as Diclofenac may increase the risk of adverse effects in these populations. Common side effects include gastrointestinal discomfort, nausea, headache, and dizziness. Use during pregnancy and lactation should be avoided unless clearly necessary. Idiaqua Injection should be used at the lowest effective dose for the shortest duration to minimize potential risks. Always consult a healthcare professional before initiating therapy.